跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 24 条关于
“RIPK3”
全部
24
临床试验
2
药物
14
机构
0
资讯
8
3个月前
Targeting ZBP1: How a Cellular Alarm System Could Overcome Cancer Immunotherapy Resistance
10个月前
Novel Cell Death Pathways Transform Melanoma Immunotherapy: Targeting Ferroptosis, Pyroptosis, and Necroptosis
去年
RIPK1 Inhibitor Pipeline Shows Promise Despite Sanofi Setback in Multiple Sclerosis
去年
Accropeutics' RIPK2 Inhibitor AC-101 Advances in Ulcerative Colitis Trials
2年前
Sanofi and Denali's RIPK1 Inhibitor Fails in Phase 2 ALS Trial
4个月前
Accro Bioscience Secures $50M Series C to Advance RIPK2 Inhibitor AC-101 for Ulcerative Colitis
去年
Sanofi and Denali Terminate Phase 2 Multiple Sclerosis Trial of RIPK1 Inhibitor Oditrasertib After Disappointing Results
去年
Oncodesign Precision Medicine Presents Positive Phase 1 Data for RIPK2 Inhibitor OPM-101 in Healthy Volunteers